Sepsis is a global health problem that carries a high risk of death.1
A recent global assessment of the mortality rate of patients with sepsis treated in an intensive care unit found that over one-third died without leaving hospital. Alarmingly, the number of hospital admissions for sepsis has increased up to three-fold over the last decade.2
The quick recognition of symptoms and accurate identification of pathogens are absolutely critical for successful therapy.
The LightCycler® SeptiFast Tests enable rapid identification of the 25 most common pathogens known to cause downstream blood infections, including methicillin resistant Staphylococcus aureus (MRSA).
- Vincent JL, Marshall JC, Namendys-Silva SA, et al: Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2(5):380-386.
- Seymour CW, Rea TD, Kahn JM, Walkey AJ, Yealy DM, Angus DC. Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med. 2012;186(12):1264-1271.